Quick Takeaways
- Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G for Achieve Life Sciences, Inc. Common Stock, par value $0.001 per share (ACHV).
- Disclosed ownership: 6.5%.
- Date of event: 17 Apr 2026.
Frazier Life Sciences Public Fund, L.P. - 17 Apr 2026 SCHEDULE 13G Report for Achieve Life Sciences, Inc. Common Stock, par value $0.001 per share (ACHV)
- Filing Manager
- Frazier Life Sciences Public Fund, L.P.
- Reporting Manager
- Frazier Life Sciences Public Fund, L.P.
- Symbol
- ACHV
- Shares outstanding
- 101,935,200 shares
- Disclosed Ownership
- 6,625,788 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Apr 2026, 16:57:11 UTC
- Date of event
- 17 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Frazier Life Sciences Public Fund, L.P. disclosed 6.5% ownership in Achieve Life Sciences, Inc. Common Stock, par value $0.001 per share (ACHV) on 17 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Apr 2026, 16:57.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (9)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 6.5% | 6,625,788 | 0 | 6,625,788 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. | |
| FHMLSP, L.P. | 6.5% | 6,625,788 | 0 | 6,625,788 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. | |
| FHMLSP, L.L.C. | 6.5% | 6,625,788 | 0 | 6,625,788 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLSP, L.L.C. | |
| Frazier Life Sciences XI, L.P. | 0.1% | 61,958 | 0 | 61,958 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. | |
| FHMLS XI, L.P. | 0.1% | 61,958 | 0 | 61,958 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. | |
| FHMLS XI, L.L.C. | 0.1% | 61,958 | 0 | 61,958 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLS XI, L.L.C. | |
| Frazier Life Sciences XII, L.P. | 0.8% | 777,090 | 0 | 777,090 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLS XII, L.L.C., GP of FHMLS XII, L.P., GP of Frazier Life Sciences XII, L.P. | |
| FHMLS XII, L.P. | 0.8% | 777,090 | 0 | 777,090 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLS XII, L.L.C., GP of FHMLS XII, L.P. | |
| FHMLS XII, L.L.C. | 0.8% | 777,090 | 0 | 777,090 | /s/ Jennifer Martin | By Jennifer Martin, CFO of FHMLS XII, L.L.C. |